Temporal restrictions and the impasse on human embryonic stem-cell research

Lancet

Volumn 364, Issue 9429, 2004, Pages 215-218

  Siegel, Andrew W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CELL DIFFERENTIATION; CELL LINE; CLINICAL RESEARCH; EMBRYO; EMBRYO CELL; FINANCIAL MANAGEMENT; GOVERNMENT; HUMAN; MEDICAL RESEARCH; MORALITY; PATENT; POLICY; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

EID: 3042756212     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16638-5     Document Type: Note

References (18)

1. Knowles L. A regulatory patchwork: human ES cell research oversight. Nat Biotechnol. 22:2004;157-163
2. The White House. Fact sheet: embryonic stem cell research, August 9, 2001. http://www.whitehouse.gov/news/releases/2001/08/20010809-1.html (accessed June 14, 2004).
3. Gesetz zur Sicherstellung des Embryonenschutzes im Zusammenhang mit Einfuhr und Verwendung menschlicher embryonaler Stammzellen: BGB1, Nr 42 S 2277, June 29, 2002. http://www.bmbf.de/pub/stammzellgesetz.pdf (accessed June 14, 2004).
4. The White House. Remarks by the President on stem cell research, August 9, 2001. http://www.whitehouse.gov/news/releases/2001/08/20010809-2.html (accessed June 14, 2004).
5. Gesetz zum Schutz von Embryonen, BGB1 S 2746-2748, 1990. http://www.bba.de/gentech/eschg.htm (accessed June 14, 2004).
6. United States Conference of Catholic Bishops. President Bush's stem cell decision, August 13, 2001. http://www.usccb.org/prolife/ issues/bioethic/ fact801.htm (accessed June 14, 2004).
7. National Institutes of Health. Stem cell information: information on eligibility criteria for federal funding of research on human embryonic stem cells. http://stemcells.nih.gov/registry/eligibilityCriteria.asp (accessed June 14, 2004).
8. Dawson L., Bateman-House A., Agnew D., Bok H., Brock D., Chakravarti A., et al. Safety issues in cell-based intervention trials. Fertil Steril. 80:2003;1077-1085
9. Public Health Service Act, 42 USC 289g-1(c) (1997).
10. National Institute for Biological Standards and Control. The UK stem cell bank at NIBSC: an overview. http://www.nibsc.ac.uk/divisions/cbi/stemcell.html (accessed June 14, 2004).
11. Medical Research Council. Stem cells: international policy discussion. http://www.mrc.ac.uk/index/strategy-strategy/strategy-science
12. Cowan C, Klimanskaya I, McMahon J, et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med. 350:2004;1353-1356
13. Cook G. 94 new stem cell lines created abroad since Bush decision. Boston Globe 2004 May 23. http://www.boston.com/news/nation/articles/2004/05/23/ 94_new_cell_lines_created_abroad_since_bush_decision/ (accessed June 14, 2004).
14. Robertson JA. Fetal tissue transplantation research is ethical: response to Burtchaell, II. IRB. 10:1988;5-8
15. Statement of Todd Dickinson, acting commissioner of patents and trademarks, before the senate appropriations committee, January 12, 1999. http://www.uspto.gov/web/offices/ac/ahrpa/opa/bulletin/stemcell.pdf (accessed June 14, 2004).
16. Amgen Inc v Chugai Pharmaceutical Co. 13 USPQ2d 1737 (D Mass 1990).
17. European Patent Office. Press release: "Edinburgh" patent limited after European Patent Office opposition hearing, July 24, 2002. http://www.european-patent-office.org/news/pressrel/2002_07_24_e.htm (accessed June 14, 2004).
18. The UK Patent Office. Inventions involving human embryonic stem cells, April, 2003. http://www.patent.gov.uk/patent/notices/practice/stemcells.htm (accessed June 14, 2004).